Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The History and Mystery of Alveolar Epithelial Type II Cells: Focus on Their Physiologic and Pathologic Role in Lung
Barbara Ruaro, Francesco Salton, Luca Braga, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2566-2566
Open Access | Times Cited: 220

Showing 1-25 of 220 citing articles:

Novel drug delivery systems and disease models for pulmonary fibrosis
Rui Li, Yizhen Jia, Xiaohan Kong, et al.
Journal of Controlled Release (2022) Vol. 348, pp. 95-114
Closed Access | Times Cited: 61
Role of DAMPs in respiratory virus-induced acute respiratory distress syndrome—with a preliminary reference to SARS-CoV-2 pneumonia
W. Land
Genes and Immunity (2021) Vol. 22, Iss. 3, pp. 141-160
Open Access | Times Cited: 60
Different Methods to Improve the Monitoring of Noninvasive Respiratory Support of Patients with Severe Pneumonia/ARDS Due to COVID-19: An Update
Paolo Pelosi, Roberto Tonelli, Chiara Torregiani, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 6, pp. 1704-1704
Open Access | Times Cited: 60
Evaluation of Correlations between Genetic Variants and High-Resolution Computed Tomography Patterns in Idiopathic Pulmonary Fibrosis
Elisa Baratella, Barbara Ruaro, Fabiola Giudici, et al.
Diagnostics (2021) Vol. 11, Iss. 5, pp. 762-762
Open Access | Times Cited: 56
Interstitial Lung Disease at High Resolution CT after SARS-CoV-2-Related Acute Respiratory Distress Syndrome According to Pulmonary Segmental Anatomy
Elisa Baratella, Barbara Ruaro, Cristina Marrocchio, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 17, pp. 3985-3985
Open Access | Times Cited: 56
An updated overview of recent advances, challenges, and clinical considerations of IL-6 signaling blockade in severe coronavirus disease 2019 (COVID-19)
Reza Elahi, Parsa Karami, Amir Hossein Heidary, et al.
International Immunopharmacology (2022) Vol. 105, pp. 108536-108536
Open Access | Times Cited: 44
Immunotherapy of inflammatory bowel disease (IBD) through mesenchymal stem cells
Huldani Huldani, Ria Margiana, Fawad Ahmad, et al.
International Immunopharmacology (2022) Vol. 107, pp. 108698-108698
Closed Access | Times Cited: 40
Acute lung injury caused by sepsis: how does it happen?
Baisheng Sun, M. Lei, Jiaqi Zhang, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 39
The role of macrophage polarization and cellular crosstalk in the pulmonary fibrotic microenvironment: a review
Bowen Zhou, Huaman Liu, Fei Xu, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Repair and regeneration of the alveolar epithelium in lung injury
Yaxuan Wang, Lan Wang, Shuaichen Ma, et al.
The FASEB Journal (2024) Vol. 38, Iss. 8
Closed Access | Times Cited: 13
Lung regeneration: diverse cell types and the therapeutic potential
Yutian Chen, Zhen Li, Gaili Ji, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 11
Alveolar macrophages: Achilles’ heel of SARS-CoV-2 infection
Zhenfeng Wang, Shunshun Li, Bo Huang
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 34
Chronic Thromboembolic Pulmonary Hypertension: An Update
Barbara Ruaro, Elisa Baratella, Gaetano Caforio, et al.
Diagnostics (2022) Vol. 12, Iss. 2, pp. 235-235
Open Access | Times Cited: 32
A bioactive gypenoside (GP-14) alleviates neuroinflammation and blood brain barrier (BBB) disruption by inhibiting the NF-κB signaling pathway in a mouse high-altitude cerebral edema (HACE) model
Yanan Geng, Jun‐Li Yang, Xiang Cheng, et al.
International Immunopharmacology (2022) Vol. 107, pp. 108675-108675
Open Access | Times Cited: 29
Role of Ferroptosis in Regulating the Epithelial–Mesenchymal Transition in Pulmonary Fibrosis
Hong Ling, Hong Xiao, Ting Luo, et al.
Biomedicines (2023) Vol. 11, Iss. 1, pp. 163-163
Open Access | Times Cited: 22
Long-term cadmium exposure induces chronic obstructive pulmonary disease-like lung lesions in a mouse model
Wenjing Wang, Kun Peng, Xue Lu, et al.
The Science of The Total Environment (2023) Vol. 879, pp. 163073-163073
Closed Access | Times Cited: 21
Mucus Hypersecretion in Chronic Obstructive Pulmonary Disease and Its Treatment
Binay Kumar Shah, Bivek Singh, Y Wang, et al.
Mediators of Inflammation (2023) Vol. 2023, pp. 1-15
Open Access | Times Cited: 21
Lung Inflammation in alpha-1-antitrypsin deficient individuals with normal lung function
Nurdan Köktürk, Nazli Khodayari, Jorge Lascano, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 20
RAGE inhibition alleviates lipopolysaccharides-induced lung injury via directly suppressing autophagic apoptosis of type II alveolar epithelial cells
Xi Xiong, Jiaying Dou, Jingyi Shi, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 19
Shenfu injection targets the PI3K-AKT pathway to regulate autophagy and apoptosis in acute respiratory distress syndrome caused by sepsis
Juan Chen, Weichao Ding, Zhe Zhang, et al.
Phytomedicine (2024) Vol. 129, pp. 155627-155627
Closed Access | Times Cited: 7
Acute lung injury: a view from the perspective of necroptosis
Jinyan Dong, Weihong Liu, Wenli Liu, et al.
Inflammation Research (2024) Vol. 73, Iss. 6, pp. 997-1018
Closed Access | Times Cited: 6
Understanding the cellular dynamics, engineering perspectives and translation prospects in bioprinting epithelial tissues
İrem Deniz Derman, Joseph Christakiran Moses, T. Pinedo Rivera, et al.
Bioactive Materials (2024) Vol. 43, pp. 195-224
Open Access | Times Cited: 6
Alveolar Type II Cells and Pulmonary Surfactant in COVID-19 Era
Andrea Čalkovská, M Kolomazník, V. Čalkovský
Physiological Research (2021), pp. S195-S208
Open Access | Times Cited: 39
Metabolic reprogramming of pulmonary fibrosis
Jiaxin Li, Xiaoxuan Zhai, Xiao Sun, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 27
The role of extracellular histones in COVID‐19
Femke de Vries, Joram Huckriede, Kanin Wichapong, et al.
Journal of Internal Medicine (2022) Vol. 293, Iss. 3, pp. 275-292
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top